Bing Catherine Wu

Bing Catherine Wu is an Associate Scientist in Multispecific Antibody Therapeutics at Zymeworks Inc. since September 2022, focusing on developing pharmacokinetics assays to support multispecific antibody programs. Previously, Bing served as a Graduate Research Assistant at The University of British Columbia from 2015 to 2021, researching synthetic host defense peptides for skin inflammation therapies. Additional research projects at The University of British Columbia include investigating peptide aggregation and its immunomodulatory effects, and analyzing Pseudomonas aeruginosa swarming motility. Bing holds a PhD in Microbiology and Immunology and a Bachelor's degree in the same field from The University of British Columbia.